Nationwide alert in China for the faulty rabies vaccine

The second largest drug manufacturing company “ Changchun Changsheng Life Sciences” were found guilty for violated national standards including usage of expired fluids and falsified production dates to produce rabies vaccine. Rabies Vaccines manufactured in China was widely exported to countries including India too.

This recent scandal of faulty Rabies Vaccines creating panic and especially in China. After taking a quick action on this, country has started a nationwide campaign to provide health consultation and free inoculation of rabies vaccines.

In India, the Drug Controller General of India also ordered immediately to withdraw rabies vaccines from the market and also banned their imports from Changchun Changsheng Life Sciences.

Healthcare centers, institutions and disease control centers have started providing consultation services for those who received or used rabies vaccines made by the company. 36,482 hospitals and health centers are designated by the China government to provide consultation. No life loss has been reported yet from the patients who injected with the faulty Rabies vaccines.

According to the report, Changchun Changsheng making use of expired fluids and false production dates is in continuity since April 2014 and had violated rules on production management and national drug standards for the vaccines.

China National Health Commission and the State Drug Administration are actively working on the issue and created an inoculation plan for patients who have injected rabies vaccines from the Changchun Changsheng company. And the patients who are getting treated and those whose required course are not yet completed can switch to vaccines from other companies at no charge.

China government also start giving free re-inoculated who have completed their courses less than a year ago and vaccination institutions will provide tracking, observation, and advisory services.

Related Posts

  • Pharma
  • June 6, 2025
  • 185 views
Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Mumbai-based pharma major Wockhardt, which is all set to launch its new class of antibiotic Zaynich targeted at treating complicated gram-negative infections in India this year, estimates that the drug…

  • Pharma
  • June 6, 2025
  • 126 views
Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

In a joint crackdown, Odisha’s Drugs Control administration and Crime Branch Special Task Force (STF) raided Unit-1 Market in Bhubaneswar on Thursday, seizing duplicate cosmetic products sold under top brand…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market

Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

Fake cosmetics racket busted in Bhubaneswar’s Unit-1 Market

Illegally stocked drugs worth Rs 5.21 lakh seized

Illegally stocked drugs worth Rs 5.21 lakh seized

Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions